[go: up one dir, main page]

MX2019006941A - Uso de compuesto de carbamato para prevenir, aliviar o tratar temblores o el sindrome de temblor. - Google Patents

Uso de compuesto de carbamato para prevenir, aliviar o tratar temblores o el sindrome de temblor.

Info

Publication number
MX2019006941A
MX2019006941A MX2019006941A MX2019006941A MX2019006941A MX 2019006941 A MX2019006941 A MX 2019006941A MX 2019006941 A MX2019006941 A MX 2019006941A MX 2019006941 A MX2019006941 A MX 2019006941A MX 2019006941 A MX2019006941 A MX 2019006941A
Authority
MX
Mexico
Prior art keywords
prevent
relieve
carbamate compound
tremor syndrome
treat
Prior art date
Application number
MX2019006941A
Other languages
English (en)
Other versions
MX391363B (es
Inventor
Ju Yi Han
Uk Yoo Jin
Sung Lee Hye
Original Assignee
Sk Biopharmaceuticals Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sk Biopharmaceuticals Co Ltd filed Critical Sk Biopharmaceuticals Co Ltd
Publication of MX2019006941A publication Critical patent/MX2019006941A/es
Publication of MX391363B publication Critical patent/MX391363B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/325—Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

La presente invención se relaciona a un uso de una composición farmacéutica que incluye un compuesto de carbamato de la fórmula química 1 y se administra para prevenir, aliviar o tratar temblores o el síndrome de temblor.
MX2019006941A 2016-12-14 2017-12-14 Uso de compuesto de carbamato para prevenir, aliviar o tratar temblores o el sindrome de temblor. MX391363B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR20160170225 2016-12-14
PCT/KR2017/014743 WO2018111009A1 (ko) 2016-12-14 2017-12-14 진전 또는 진전 증후군의 예방, 경감 또는 치료를 위한 카바메이트 화합물의 용도

Publications (2)

Publication Number Publication Date
MX2019006941A true MX2019006941A (es) 2019-09-06
MX391363B MX391363B (es) 2025-03-21

Family

ID=62558966

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2019006941A MX391363B (es) 2016-12-14 2017-12-14 Uso de compuesto de carbamato para prevenir, aliviar o tratar temblores o el sindrome de temblor.

Country Status (14)

Country Link
US (1) US11033531B2 (es)
EP (1) EP3556364B1 (es)
JP (1) JP7086076B2 (es)
KR (1) KR102635941B1 (es)
CN (1) CN110267657B (es)
AU (1) AU2017374459B2 (es)
CA (1) CA3046300A1 (es)
CL (1) CL2019001623A1 (es)
ES (1) ES3039979T3 (es)
IL (1) IL267191B2 (es)
MX (1) MX391363B (es)
MY (1) MY198417A (es)
WO (1) WO2018111009A1 (es)
ZA (1) ZA201903749B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11406620B2 (en) * 2017-11-14 2022-08-09 Sk Biopharmaceuticals Co., Ltd. Use of carbamate compound for preventing or treating diseases associated with increase in late sodium current
WO2020060251A1 (ko) * 2018-09-21 2020-03-26 에스케이바이오팜 주식회사 카바메이트 화합물 및 이를 포함하는 배합물의 급성 스트레스 장애 또는 외상 후 스트레스 장애의 예방, 경감 또는 치료를 위한 용도

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002067926A1 (en) * 2001-02-27 2002-09-06 Ortho-Mcneil Pharmaceutical, Inc. Carbamate compounds for use in preventing or treating movement disorders
CA2560796A1 (en) * 2004-03-29 2005-10-20 Merck & Co., Inc. Biaryl substituted pyrazinones as sodium channel blockers
US7598279B2 (en) 2005-04-22 2009-10-06 Sk Holdings Co., Ltd. Neurotherapeutic azole compounds
JP5201767B2 (ja) * 2007-03-05 2013-06-05 インダス バイオテック プライベート リミテッド 医薬組成物およびその調製方法
JP5683580B2 (ja) 2009-06-22 2015-03-11 エスケー バイオファーマシューティカル カンパニー リミテッド カルバミン酸（ｒ）−１−アリール−２−テトラゾリル−エチルエステルの製造方法
US8404461B2 (en) 2009-10-15 2013-03-26 SK Biopharmaceutical Co. Ltd. Method for preparation of carbamic acid (R)-1-aryl-2-tetrazolyl-ethyl ester
WO2014142477A1 (en) * 2013-03-12 2014-09-18 Bio-Pharm Solutions Co., Ltd. Phenyl carbamate compounds for use in preventing or treating pediatric epilesy and epilesy-related syndromes
KR102489052B1 (ko) * 2016-05-19 2023-01-16 에스케이바이오팜 주식회사 섬유근육통 또는 섬유근육통의 연관된 기능적 증후군을 예방 또는 치료하기 위한 카바메이트 화합물의 용도

Also Published As

Publication number Publication date
CL2019001623A1 (es) 2019-08-23
AU2017374459A1 (en) 2019-07-04
MX391363B (es) 2025-03-21
JP7086076B2 (ja) 2022-06-17
IL267191A (es) 2019-07-31
CN110267657B (zh) 2022-12-13
WO2018111009A1 (ko) 2018-06-21
ES3039979T3 (en) 2025-10-28
IL267191B2 (en) 2023-05-01
AU2017374459B2 (en) 2023-04-27
KR102635941B1 (ko) 2024-02-13
EP3556364A1 (en) 2019-10-23
JP2020502137A (ja) 2020-01-23
US20190336481A1 (en) 2019-11-07
EP3556364B1 (en) 2025-08-27
BR112019012000A2 (pt) 2019-10-29
IL267191B1 (en) 2023-01-01
EP3556364A4 (en) 2020-06-17
MY198417A (en) 2023-08-29
RU2019121914A (ru) 2021-01-15
CA3046300A1 (en) 2018-06-21
KR20190087573A (ko) 2019-07-24
RU2019121914A3 (es) 2021-04-21
ZA201903749B (en) 2022-01-26
US11033531B2 (en) 2021-06-15
CN110267657A (zh) 2019-09-20

Similar Documents

Publication Publication Date Title
DOP2019000117A (es) Nuevos derivados de quinolina
BR112017003658A2 (pt) composto, mistura, métodos para tratamento de uma doença e para inibição de uma glicosidase, e, composição farmacêutica.
EA201791420A1 (ru) Соединения триазолопиримидина и их применения
UY37789A (es) Nuevos derivados de azaquinolina
BR112015022197A8 (pt) uso de um composto para fabricação de um medicamento ou composição farmacêutica para o tratamento de cataplexia
MX2016011810A (es) Composiciones farmaceuticas de compuestos terapeuticamente activos y sus metodos de uso.
EA201991580A1 (ru) Пиримидиновое соединение и его фармацевтическое применение
EA201990400A1 (ru) Соединения и композиции и их применение
MX2018014080A (es) Uso de compuesto de carbamato para prevenir o tratar fibromialgia o sindrome funcional asociado con fibromialgia.
MX2020004694A (es) Composiciones farmaceuticas inyectables de isoxazolina y su uso contra la infestacion de parasitos.
MX382175B (es) Composiciones de profármaco de monometilfumarato
CL2018003431A1 (es) Tratamiento de la enfermedad de parkinson.
MX387658B (es) Métodos para tratar y/o prevenir queratosis actínica.
AR094707A1 (es) Compuesto de quinazolin-4-amina, composición farmacéutica que lo comprende y su uso para el tratamiento de una enfermedad mediada por la quinasa rip2
MX2019004232A (es) Compuestos terapéuticos y métodos para utilizarlos.
SV2018005702A (es) Compuestos de 1,3,4-tiadiazol y su uso en el tratamiento del cancer
MX388592B (es) Compuestos y metodos terapeuticos.
MX2020004842A (es) Compuestos heterociclicos antiinfecciosos y sus usos.
CL2019001618A1 (es) Uso de compuestos de carbamato para prevención, alivio o tratamiento del trastorno bipolar.
CL2019001623A1 (es) Uso de compuesto de carbamato para prevenir, aliviar o tratar temblores o el síndrome de temblor.
MX392555B (es) Composiciones y métodos para el tratamiento de resistencia a la insulina.
CL2019001617A1 (es) Preparación líquida parenteral que comprende compuesto de carbamato.
MX2018014081A (es) Uso de compuesto de carbamato para prevenir o tratar neuralgia trigeminal.
MX2021004342A (es) Uso de compuesto de carbamato para prevenir, aliviar o tratar neuropatía periférica diabética o neuropatía periférica inducida por quimioterapia.
EA201991819A1 (ru) Пастилка